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CLINICAL OBSERVATION
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Abstract
OBJECTIVE: To test the clinical curative effect of
Jiutengzhuyu tablets, a patented Chinese vine-de-
rived drug used for promoting blood circulation,
on women with oviducal obstruction.
METHODS: Patients with tubal infertility were di-
vided randomly into two groups: 58 patients in the
treatment group and 57 in a control group. The
treated patients took Jiutengzhuyu tablets orally
for 25 days. The control group received an intrauter-
ine infusion of 5 mg dexamethasone sodium phos-
phate, 4000 units of chymotrypsin, 80 000 units of
gentamicin sulfate dissolved in 20 mL of normal sa-
line at 1 mL/min. After 3 months of treatment, the
curative effect on tubal patency was assessed and a
1-year follow-up visit was used to document any
pregnancies.
RESULTS: The total effective rate was 78% in the
treatment group and 32% in the control group
with a statistically significant difference (χ2=24.57,
P<0.01).
CONCLUSION: Jiutengzhuyu was effective in treat-
ing infertility caused by tubal infertility with a Tradi-
tional Chinese Medicine diagnosis of blood stasis.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
The incidence of infertility among couples of childbear-
ing age has been rising year by year.1 Infertility associat-
ed with an obstructed oviduct is the most common
cause, accounting for 20%-40% of cases. Moreover,
there has been a tendency for the incidence of tubal in-
fertility to rise in recent years. This form of infertility,
one of the most difficult to treat,2 is caused by adhe-
sion and stiffness of the oviduct arising after chronic
pelvic inflammation or caused by obstructing scar tis-
sues, making oviducts lose the ability to transport sper-
matozoa, oocytes and embryos.3 In Western Medicine,
assessing tubal patency by instilling liquid contrast me-
dium and hysterosalpingography, and treatments in-
volving surgery and intervention therapy are mainly
used to treat this type of infertility. However, even after
expensive surgery, the pregnancy rate of 20%-30%4 re-
mains poor because of re-adhesions and heterotopic
pregnancies.2 Although treatment of this form of infer-
tility at present has achieved some effects, the therapy
is very prolonged.5 In TCM, treatment of this form of
infertility with drugs for promoting blood circulation
has achieved some but not ideal curative effects. Based
on clinical observations for many years, we decided to
trial Jiutengzhuyu tablets, a pure Chinese vine prepara-
tion used for promoting blood circulation. At present,
there are no systematic data on treating tubal infertility
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with this TCM preparation. Our observations from
January 1998 to March 2012 on the effects of Jiuteng-
zhuyu tablets are reported as follows.
METHODS
Standards for selecting cases
Diagnostic standards: The TCM standard for diagnos-
ing infertility used here was based on TCM Gynecolo-
gy.6 1) Infertility in a woman is defined as inability to
get pregnant after one year with the husband having
normal reproductive function and without using any
contraception. 2) Women with physiological defects or
deformities of the reproductive system were excluded.
According to the TCM standard for differentiating syn-
dromes issued by the Health Ministry of the People's
Republic of China,7 infertility caused by obstructed ovi-
duct belongs to the syndrome of "blood stasis". The di-
agnostic criteria used in this study were as follows. 1) A
married woman has not been pregnant for a long time.
2) At the late stage of menstruation, purple blood
lumps can be seen. 3) Cramping pain in the lower ab-
domen is severe, especially before menstruation. 4) Pe-
techiae can be seen on the tongue. 5) The pulse is taut
or uneven. Patients with 1) plus three other items of
the list can be diagnosed as suffering from blood stasis.
The Western Medical standard for diagnosing infertili-
ty caused by an obstructed oviduct was drawn up in ref-
erence to the standard for diagnosing infertility caused
by salpingitis issued by the Health Ministry of the Peo-
ple's Republic of China.7 1) Contrast X-rays of the
uterus and oviduct were used to confirm obstruction of
the oviduct. 2) Tubal patency testing by liquid contrast
medium instillation with hysterosalpingoscopy con-
firmed obstruction of the oviduct. Patients with one of
these two features were diagnosed as having an ob-
structed oviduct.
The standard for diagnosing the degree of tubal paten-
cy was worked out at the department of gynecology
and obstetrics according to the status of the uterus and
oviduct following the instillation of contrast medium.8
Degree I means obstruction at the tubal angle, degree
II means obstruction of the isthmic portion, degree III
means obstruction of the fimbria, degree IV means
that although contrast medium can pass through, the
oviduct still shows adhesions with poor diffusion, and
degree V means that the contrast medium reaches the
bottom of the pelvic cavity easily.
Standard of testees: The standard of testees was drawn
up according to the principles for directing clinical re-
search into treatment of female infertility with new
Chinese drugs published by the Health Ministry of the
People's Republic of China.7
Inclusion criteria: The inclusion criteria for this study
were as follows. 1) Patients were diagnosed as suffering
from infertility and the syndrome of blood stasis by
TCM and as having an obstructed oviduct as defined
by Western medical criteria. 2) Using hysterosalpingos-
copy, tubal patency testing with contrast liquid instilla-
tion confirmed an obstructed oviduct. 3) Patients need-
ed to be more than 22 and less than 45 years old.
Exclusion criteria: Patients were excluded if they
showed any of the following features. 1) Infertility
caused by a physiological defect or deformity. 2) Infer-
tility caused by genetic factors. 3) Infertility caused by
endometriosis, myometrial disease, hysteromyoma or
uterine hypoplasia. 4) The husband had abnormal re-
productive function. 5) Age less than 22 or more than
45 years. 6) Any severe primary diseases such as tuber-
culosis, diseases to the cardiac blood vessels, liver, kid-
ney and hematopoietic system or mental illness. 7)
Any sensitivity to the drugs being researched. 8) Pa-
tients with severe adverse incidents or complications
that would compromise the research. 9) Patients who
did not conform to inclusion criteria or did not take
drugs as planned (i.e. they stopped taking the medica-
tions, changed drugs or took additional drugs during
treatment). This made it difficult to judge any curative
effect, or produced incomplete data that could influ-
ence our judgment of curative effects or impair safety.
Indices for observation
These were based on observations of safety and cura-
tive effect based on the principles of directing clinical
research into the treatment of female infertility with
new Chinese drugs issued by the Health Ministry of
the People's Republic of China.16
Observation of safety factors：All patients underwent
general health checkups, routine laboratory tests of
blood, urine and stool samples and clinical tests of
heart, liver and kidney functions.
Observation of curative effect：After 3 months of treat-
ment and 3-7 days after menstruation, evaluations of
the uterus and oviducts were used to compare tubal pa-
tency between the two groups. Any pregnancy was not-
ed within 1 year to assess the curative effect of either
treatment and the incidence of any ectopic pregnancy
was noted. Any improvements in symptoms were re-
corded.
General data
A cohort of 120 patients conforming to our inclusion
criteria who presented in our hospital from January
1998 to March 2012 was divided randomly into two
groups of 60. In the treatment group, one patient us-
ing other drugs during treatment and another having
incomplete data were excluded. In the control group,
one patient without a follow-up visit and two other pa-
tients who withdrew by themselves were excluded. Fi-
nally, in the treatment group of 58 cases, 66 of the 116
oviducts were obstructed to degree I, 29 oviducts to de-
gree II and 21 oviducts to degree III. The mean age of
the patients was (32±5) years. The mean duration of
prior infertility was (7±3) years. There were 20 patients
with primary infertility and 38 with secondary infertili-
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ty. These patients were diagnosed by TCM as having a
blood stasis syndrome. There were 30 patients with a
history of induced abortion and 36 with chronic pelvic
inflammation. In the control group of 57 cases, two pa-
tients had one oviduct removed because of an ectopic
pregnancy. Of the 112 oviducts, 63 were obstructed to
degree I, 28 to degree II and 21 to degree Ⅲ. The
mean age was (32±5) years and the mean duration of
prior infertility was (7±3) years. There were 19 patients
with primary infertility and 38 with secondary infertili-
ty. These patients were diagnosed by TCM as having a
blood stasis syndrome. There were 29 patients with a
history of induced abortion and 35 with chronic pelvic
inflammation. There were no statistically significant
differences between the treatment and control groups
in the incidence or degree of tubal patency, in age, in
the duration of infertility, in the incidence of primary
or secondary infertility, in syndrome type, a history of
induced abortion, or the incidence of chronic pelvic in-
flammation (all P>0.05).
Therapy
On the first day of menstruation, the patients in the
treatment group began taking Jiutengzhuyu tablets. A
total dose of 400 mL per day was taken orally with
warm water in the morning and evening; 25 doses
were taken daily every menstrual cycle. The treatment
course lasted 3 months. The pill consists of Jixueteng
(Caulis Spatholobi) 15 g, Qingfengteng (Caulis Sino-
menii) 10 g, Daxueteng (Caulis Sargentodoxae) 15 g,
Luoshiteng (Caulis Trachelospermi) 10 g, Rendong-
teng (Caulis Lonicerae) 10 g, Shouwuteng (Caulis
Polygoni Multiflori) 10 g, Tongguanteng 10 g, Tianjix-
ueteng 30 g, Huangteng (Caulis Fibraureae) 10 g and
Huangqi (Radix Astragali seu Hedysari) 15 g. The au-
thors have used Juteng Zhuyu tablets to treat infertility
caused by obstructed oviduct for many years. On Sep-
tember 7, 2011, the State Patent Bureau awarded a pat-
ent of invention with patent number ZL 2010 1
0215494.7 to Jiutengzhuyu tablets.9 The description of
the invention is "a drug used to treat infertility caused
by obstructed oviduct and its preparatory method".
On the first day of menstruation, the control group re-
ceived an intrauterine infusion of 5 mg dexamethasone
sodium phosphate (Chenxin Pharmaceutical Co. Ltd.,
Jiangsu, H31022112), 4000 units of chymotrypsin
(First Biochemical Pharmaceutical Co. Ltd. of Shang-
hai, H31022112) and 80 000 units of gentamicin sul-
fate (Chenxin Pharmaceutical Co. Ltd. H37021973)
dissolved in 20 mL of normal saline and injected at 1
ml/min. If there were no adverse reactions, the injec-
tion was performed three times in a row. If blood was
discharged from the vagina after injection, the infusion
was suspended until the next menstruation. After treat-
ment, sexual intercourse and bathing were prohibited
for two weeks. The treatment course lasted for three
menstrual cycles
After treatment, a follow-up visit was paid one year lat-
er. The patients were instructed not to take any other
drugs for the disease during treatment and up to the
follow-up visit.
RESULTS
Standard of curative effect
1) "Cure" was defined when unilateral or bilateral tub-
al patency was confirmed by the techniques listed in
the Western medical standard , the patient was preg-
nant within 1 year and symptoms disappeared com-
pletely. 2) "Improvement" meant that unilateral or bi-
lateral tubal patency was confirmed but the patient was
not pregnant within 1 year and symptoms were alleviat-
ed. 3) An "ineffective" treatment meant that no im-
provement in the obstructed oviduct could be con-
firmed, the patient was not pregnant within 1 year and
the symptoms and experimental indexes were un-
changed or even aggravated.
Statistical methods
Data was analyzed by SPSS 11.5 and expressed as the
mean ± SD. Student's t test was used for comparing
means and the Chi-square test was applied to numeric
data.
Comparisonof tubal patencybetween groups (Table1)
After 3 months of treatment and 3-7 days after men-
struation, tubal patency was compared between the
two groups with the results as follows.
Comparison of pregnancy rate between the two
groups
Within 1 year after treatment, 30 of 58 patients in the
treatment group had an intrauterine pregnancy (52%)
versus 10 of 57 patients in the control group (18%).
Of these 10 pregnant women there were two cases of
tubal pregnancy (20%), and eight cases with an intra-
uterine pregnancy (80% ). The pregnancy rate in the
treatment group was significantly higher than in the
control group (χ2=14.81, P<0.01).
Comparison of curative effect between the two
groups (Table 2)
Safety and adverse reactions
No abnormalities were seen in the check-up items be-
fore and after treatment in the two groups. In the con-
trol group, one patient had nausea and vomiting after
medication, and blood flowed from the vagina of an-
other patient after intrauterine injection but the bleed-
ing stopped quickly after suspension of injection.
DISCUSSION
In ancient TCM medical books, there is no term for
"obstructed oviduct", but its clinical characteristics can
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be seen in discussions on "menstruation", "abdominal
pain of women" and "infertility".10 At present, promot-
ing blood circulation to alleviate blood stasis is the
main method for treating infertility caused by salpingi-
tis because blood stasis plays a decisive role in causing
the disease.2
It is difficult to cure lingering diseases such as oviducal
obstruction.2 Through clinical practice and experimen-
tal research for many years, the authors believe that an
obstructed oviduct is basically caused by blockage of
blood vessels by blood stasis and Chinese vine-based
drugs have better effects than general drugs for promot-
ing blood circulations.11 In the recipe we use, Jixueteng
and Tianjixuetang can promote blood circulation,
nourish the blood, clear meridians and regulate the im-
mune system in two ways.12 They reduce the levels of
blood lipids, resist atherosclerosis and promote phos-
phorus metabolism in the kidney and uterus, thus act-
ing to reduce edema and improve uterine function.11
Their extract inhibits the activation of anti-HIV re-
verse transcriptase and blocks herpes simplex virus I in-
fection and platelet aggregation.11 Daxueteng, also
called Hongteng, can promote blood circulation, clear
away heat and remove toxins. Its decoction strongly in-
hibits the proliferation of Staphylococcus aureus and
Streptococcus B, and moderately inhibits the prolifera-
tion of Escherichia coli, Staphylococcus albus, Neisse-
ria catarrhalis, Streptococcus A and Pseudomonas aeru-
ginosa.13 It also has the effect of preventing abdominal
adhesions after surgery and affects gastrointestinal
smooth muscle.11 The triterpenoid saponins in Dax-
ueteng have antiviral effects.11 Qingfengteng,
Luoshiteng and Rendongteng can clear meridians. Ren-
dongteng can also clear away heat and remove toxins.
Lignans in Luoshiteng have effects similar to phytoes-
trogens.11 Tongguanteng can remove phlegm, clean
away heat and eliminate toxins. Huangteng can clear
away heat, remove toxins, purge pathogenic fire and re-
lax the bowels. Shouwuteng can nourish the blood,
calm the mind and clear collaterals. Huangqi can sup-
plement Qi, elevate Yang, induce urination, reduce
swelling, generate fluid, nourish the blood, eliminate
stagnation, relieve numbness, remove toxins, discharge
pus, astringe sore and produce muscles.
Tubal infertility is associated with an abnormal im-
mune function and the secretion of cellular immune
factors. These can arise when menstruation or endome-
trial inflammation damages the endometrium, or when
there is repeated stimulation of the vagina by spermato-
zoa after sexual intercourse. Infections or sexual inter-
course during menstruation can also damage the vagi-
nal mucosa. In such situations, spermatozoa and anti-
genic substances easily enter the blood system to stimu-
late the female immune system and induce female B
lymphocytes to produce anti-sperm antibodies.14 One
of the good effects of Jiutengzhuyu tablets is its ability
to regulate immune responses, eliminating inflamma-
tion and resisting viral infections.
Researchers have discovered in recent years that abnor-
mal death (apoptosis) of cells takes part in the develop-
ment of tubal infertility and is controlled by many fac-
tors. The genes controlling cell death can be divided in-
to inductive and inhibitive types. The gene causing
B-cell lymphoma/leukemia type 2 (Bcl-2) is an inhibi-
tive one. Excessive expression of Bcl-2 can prevent or
delay the division of normal cells through inhibiting
apoptosis, prolonging the life of cells and making them
proliferate. When infected by Streptococcus and Staph-
ylococcus species and E. coli, the oviduct undergoes in-
flammation and its epithelial cells die.15 Epidermal
growth factor receptor (EGFR), a membrane surface
sensor that acts as a tyrosine-activating enzyme is
found in epidermal and matrix cells, especially in the
epithelium of obstructed oviducts. Highly expressed
EGFR strengthens the reaction of epithelial cells to
growth factors and combines with receptors influenc-
ing the proliferation and division of oviduct epithelial
cells and further aggravating inflammation.16 There-
fore, EGFR might play a role in promoting the genera-
tion and development of tubal infertility. Intercellular
adhesive molecule-1 (ICAM-1) is an immunoglobulin
Table 2 Comparison of curative effects between the two
groups
Note: There was a statistically significant difference between the
two groups (χ2 = 24.57, P<0.01).
Group
Treatment
group
Control
group
Cure
30
10
Improvement
15
8
Ineffective
ness
13
39
Total
effective
rate (%)
77.58
31.58
Table 1 Comparison of tubal patency rates between the two groups
Note: There was a statistically significant difference between the two groups after the treatment (χ2 = 49.53, P<0.01).
Group
Treatment group
Control group
Time
before treatment
after treatment
before treatment
after treatment
Cases
58
58
57
57
Oviducts
116
116
112
112
Ⅰ
66
7
63
35
Ⅱ
29
8
28
21
Ⅲ
21
10
21
20
Ⅳ
0
30
0
16
Ⅴ
0
61
0
20
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(also called CD54) that is an important adhesive factor
on cellular surfaces. Activating leukocytes, releasing
large amounts of inflammatory molecules17,18 and los-
ing the function of regulating the balance of network
further give rise to the obstruction of blood capillaries
and cause local ischemia. Therefore, adhesion of leuko-
cytes to epithelial cells is one of the key links by which
inflammation can damage organs. The expression of
Bc1-2, EGFR and ICAM-1 are important causes of
tubal infertility. The Jiutengzhuyu tablets might
achieve good curative effects by interfering with the ac-
tions of Bcl-2, EGFR and ICAM-1, but the putative
mechanism needs further study.
To sum up, this research has shown that Jiutengzhuyu,
a Chinese vine-based drug used in TCM for promot-
ing blood circulation, produced good oviduct-clearing
effects and no toxic side-effects. It could safely and reli-
ably achieve a high rate of intrauterine pregnancy
among these women with tubal infertility.
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